tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Burns, 658 are a BUY (92.29%), 55 are a HOLD (7.71%).
Analyst Robert Burns, carries an average stock price target met ratio of 27.28% that have a potential upside of 39.98% achieved within 124 days.
Robert Burns’s has documented 1,363 price targets and ratings displayed on 57 stocks. The coverage was on Healthcare, Basic Materials, Technology sectors.
Most recent stock forecast was given on ZYME, Zymeworks.
Analyst best performing recommendations are on PRLD (PRELUDE THERAPEUTICS).
The best stock recommendation documented was for COGT (COGENT BIOSCIENCES) at 11/4/2025. The price target of $21 was fulfilled within 6 days with a profit of $6.87 (48.62%) receiving and performance score of 81.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Sep-2021
$1.75
$-0.27 (-13.37%)
$5
2 years 2 months 15 days ago
(27-Aug-2024)
1/6 (16.67%)
$0.07 (4.17%)
2
Hold Since 14-May-2024
2 years 2 months 21 days ago
(21-Aug-2024)
0/5 (0%)
$37.88 (532.02%)
Buy Since 11-Jan-2022
$1.5
$-0.52 (-25.74%)
2 years 2 months 21 days ago
(21-Aug-2024)
0/3 (0%)
$-0.05 (-3.23%)
Buy Since 18-Apr-2018
$49
$46.98 (2325.74%)
4 years 11 months 10 days ago
(01-Dec-2021)
0/3 (0%)
$28.91 (143.90%)
Buy Since 24-Nov-2021
$49
$46.98 (2325.74%)
4 years 11 months 10 days ago
(01-Dec-2021)
1/2 (50%)
$28.91 (143.90%)
32
Which stock is Robert Burns most bullish on?
Which stock is Robert Burns most reserved on?
